| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; roundworm ; fig 5j
| Park H, Choi D, Park J, Sim C, Park S, Kang S, et al. Scalable and Isotropic Expansion of Tissues with Simply Tunable Expansion Ratio. Adv Sci (Weinh). 2019;6:1901673 pubmed publisher |
- immunohistochemistry - frozen section; mouse; 1:3000; loading ...; fig 2b
| Ham S, Kim H, Yoon J, Kim H, Song B, Choi J, et al. Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease. Int J Mol Sci. 2019;20: pubmed publisher |
| Masato A, Plotegher N, Terrin F, Sandre M, Faustini G, Thor A, et al. DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease. NPJ Parkinsons Dis. 2023;9:42 pubmed publisher |
| Li Y, Wang T, Meng L, Jin L, Liu C, Liang Y, et al. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease. Neuropathol Appl Neurobiol. 2023;49:e12860 pubmed publisher |
| Dadgar Kiani E, Bieri G, Melki R, Gitler A, Lee J. Mesoscale connections and gene expression empower whole-brain modeling of α-synuclein spread, aggregation, and decay dynamics. Cell Rep. 2022;41:111631 pubmed publisher |
| Yuan X, Yang Y, Liu C, Tian Y, Xia D, Liu Z, et al. Fine Particulate Matter Triggers α-Synuclein Fibrillization and Parkinson-like Neurodegeneration. Mov Disord. 2022;37:1817-1830 pubmed publisher |
| Kim H, Maeng H, Kim J, Yoon J, Oh Y, Paek S, et al. Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease. Int J Mol Sci. 2022;23: pubmed publisher |
| Magalh xe3 es P, Lashuel H. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies. NPJ Parkinsons Dis. 2022;8:93 pubmed publisher |
| Creed R, Memon A, Komaragiri S, Barodia S, Goldberg M. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function. Acta Neuropathol Commun. 2022;10:78 pubmed publisher |
| Park H, Kam T, Peng H, Chou S, Mehrabani Tabari A, Song J, et al. PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease. Cell. 2022;185:1943-1959.e21 pubmed publisher |
| Saveri P, Magri S, Maderna E, Balistreri F, Lombardi R, Ciano C, et al. DNAJB2-related Charcot-Marie-Tooth disease type 2: Pathomechanism insights and phenotypic spectrum widening. Eur J Neurol. 2022;29:2056-2065 pubmed publisher |
| Cai W, Srivastava P, Feng D, Lin Y, Vanderburg C, Xu Y, et al. Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease. Mol Neurodegener. 2022;17:16 pubmed publisher |
| Yoon Y, You J, Kim T, Ahn W, Kim M, Son K, et al. Senescence and impaired DNA damage responses in alpha-synucleinopathy models. Exp Mol Med. 2022;54:115-128 pubmed publisher |
| Yan M, Xiong M, Dai L, Zhang X, Zha Y, Deng X, et al. Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson's disease. NPJ Parkinsons Dis. 2022;8:1 pubmed publisher |
| Giannoccaro M, Avoni P, Rizzo G, Incensi A, Infante R, Donadio V, et al. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome. J Parkinsons Dis. 2022;12:585-591 pubmed publisher |
| Yuan X, Yang Y, Xia D, Meng L, He M, Liu C, et al. Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson's Disease Pathology. Front Neurosci. 2021;15:807988 pubmed publisher |
| Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, et al. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biol. 2021;47:102134 pubmed publisher |
| Chung C, Chan L, Chen J, Hung Y, Hong C. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease. Biomolecules. 2021;11: pubmed publisher |
| Stykel M, Humphries K, Kamski Hennekam E, Buchner Duby B, Porte Trachsel N, Ryan T, et al. α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathology. Cell Rep. 2021;35:109099 pubmed publisher |
| Zhu G, Harischandra D, Ghaisas S, Zhang P, Prall W, Huang L, et al. TRIM11 Prevents and Reverses Protein Aggregation and Rescues a Mouse Model of Parkinson's Disease. Cell Rep. 2020;33:108418 pubmed publisher |
| Kim H, Shin J, Lee Y, Yun S, Maeng H, Lee Y. Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson's Disease via a Vitamin D Receptor-Dependent Pathway. Int J Mol Sci. 2020;21: pubmed publisher |
| Dastidar S, Pham M, Mitchell M, Yeom S, Jordan S, Chang A, et al. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response. J Neurosci. 2020;40:8734-8745 pubmed publisher |
| Creed R, Goldberg M. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils. Neuroscience. 2020;437:64-75 pubmed publisher |
| Stoyka L, Arrant A, Thrasher D, Russell D, Freire J, Mahoney C, et al. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. Neurobiol Dis. 2020;134:104708 pubmed publisher |
| Cuddy L, Wani W, Morella M, Pitcairn C, Tsutsumi K, Fredriksen K, et al. Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein. Neuron. 2019;104:869-884.e11 pubmed publisher |
| Schaser A, Osterberg V, Dent S, Stackhouse T, Wakeham C, Boutros S, et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep. 2019;9:10919 pubmed publisher |
| Kim S, Kwon S, Kam T, Panicker N, Karuppagounder S, Lee S, et al. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron. 2019;103:627-641.e7 pubmed publisher |
| Bieri G, Brahic M, Bousset L, Couthouis J, Kramer N, Ma R, et al. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons. Acta Neuropathol. 2019;137:961-980 pubmed publisher |
| Hu D, Sun X, Liao X, Zhang X, Zarabi S, Schimmer A, et al. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Acta Neuropathol. 2019;137:939-960 pubmed publisher |
| Yamasaki T, Holmes B, Furman J, Dhavale D, Su B, Song E, et al. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics. J Biol Chem. 2019;294:1045-1058 pubmed publisher |
| Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, et al. Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. Acta Neuropathol Commun. 2018;6:53 pubmed publisher |
| Ryan T, Bamm V, Stykel M, Coackley C, Humphries K, Jamieson Williams R, et al. Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein. Nat Commun. 2018;9:817 pubmed publisher |
| Cai W, Feng D, Schwarzschild M, McLean P, Chen X. Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice. EBioMedicine. 2018;29:13-22 pubmed publisher |
| Groveman B, Orru C, Hughson A, Raymond L, Zanusso G, Ghetti B, et al. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC. Acta Neuropathol Commun. 2018;6:7 pubmed publisher |
| Bottani E, Cerutti R, Harbour M, Ravaglia S, Doğan S, Giordano C, et al. TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex III. Mol Cell. 2017;67:96-105.e4 pubmed publisher |
| Covell D, Robinson J, Akhtar R, Grossman M, Weintraub D, Bucklin H, et al. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. Neuropathol Appl Neurobiol. 2017;43:604-620 pubmed publisher |
| Doppler K, Jentschke H, Schulmeyer L, Vadász D, Janzen A, Luster M, et al. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol. 2017;133:535-545 pubmed publisher |
| Lee J, Derkinderen P, Kordower J, Freeman R, Munoz D, Kremer T, et al. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease. J Neuropathol Exp Neurol. 2017;76:2-15 pubmed publisher |
| Adamowicz D, Roy S, Salmon D, Galasko D, Hansen L, Masliah E, et al. Hippocampal ?-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology. J Neurosci. 2017;37:1675-1684 pubmed publisher |
| Sampson T, Debelius J, Thron T, Janssen S, Shastri G, Ilhan Z, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016;167:1469-1480.e12 pubmed publisher |
| Breid S, Bernis M, Babila J, Garza M, Wille H, TAMGUNEY G. Neuroinvasion of ?-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation. J Virol. 2016;90:9182-93 pubmed publisher |
| Doppler K, Volkmann J, Sommer C. Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols?. Brain. 2016;139:e5 pubmed publisher |
| Volpicelli Daley L, Luk K, Lee V. Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9:2135-46 pubmed publisher |
